Posted by Russell Korobkin:
Stem Cell Advance Raises New Questions:
http://volokh.com/archives/archive_2009_07_19-2009_07_25.shtml#1248384847


   Two respected scientific journals today reported that Chinese
   researchers have created baby mice out of induced pluripotent stem
   cells ("iPSCs"), an advance that raises difficult ethical questions
   and could reignite the culture-war battles over stem cell research
   that have subsided over the last two years.

   Many conservatives oppose human embryonic stem cell (hESC) research,
   and President George W. Bush severely limited its funding, because the
   five-day old embryos (called blastocysts) that are used are living
   organisms and, if implanted into a uterus, could mature into people.
   Although President Obama lifted the Bush funding restrictions, the NIH
   released new guidelines that are still solicitous of the discomfort
   many Americans feel about using blastocysts for medical research: the
   Obama administration will fund such research only if the blastocysts
   used are "extras" created in in vitro fertilization clinics and would
   be otherwise be destroyed anyway. Want to create a blastocyst in a
   test tube in order to produce stem cells? Don't look for federal
   funding, even from a Democratic administration.

   The new federal regulations have provoked relatively little media
   attention, in part because most scientists have believed for the last
   year or two that hESCs are a transitional technology about to be
   overtaken by a newer one. In late 2007, scientists succeeded in
   reprogrammed ordinary adult skin cells (and other types of adult
   cells) into cells that seem to behave, for all practical purposes,
   like hESC cells. Scientists still aren't sure that these new iPSCs
   will behave exactly the same as hESCs for purposes of medical
   research, but the available evidence looks good, and iPSCs have a
   number of advantages over hESCs. They are much easier to produce than
   hESCs, and unlike hESCs, iPSCs offer the potential of allowing
   scientists to one day use a patient's own cells as the basis for
   creating a stem cell treatment that would not create problems of
   immune system rejection. And, of course, iPSCs do not come from
   embryos that could develop into a person, so iPSC research has met
   with widespread approval by conservatives who oppose hESC research.

   But what now? If an iPSC can develop into a baby, just as a blastocyst
   can, why is it any less troubling to use iPSCs for medical research
   than it is to use hESCs? One possible response is that iPSCs can't
   become people without human intervention, but the same can be said of
   the blastocysts created in test tubes that are used for hESC research,
   which need to be placed in a womb. A difference between iPSCs and
   blastocysts is that the latter have a new, unique genome, whereas the
   former have the same genome as their donor. But we don't think
   identical twins are any less morally valuable because they lack a
   unique genome, and we wouldn't think that a cloned person was not a
   person, just because she had the same genome as her genetic donor.

   My view is that today's development underscores the logical problem
   with treating blastocysts as if they have the same moral worth as a
   person. If it seems implausible that we should treat every skin cell
   as if it were a person, this is because the foundation of personhood
   is not a human genome plus potential. There must be something more,
   whether it be a neuronal structure, sentience, consciousness, the
   ability to image a future, etc. But for the unconvinced -- and
   especially those whose religious or ideological commitments make them
   opposed to any research using blastocysts -- opposition to iPSC
   research might be the only internally consistent position to take.

_______________________________________________
Volokh mailing list
[email protected]
http://lists.powerblogs.com/cgi-bin/mailman/listinfo/volokh

Reply via email to